weight loss drugs
-
Eli Lilly Stock Faces ‘Reduce’ Warning Amid Mixed Data
Eli Lilly stock navigates a volatile week as positive clinical data meets a sharp analyst downgrade, sparking debate over the future of the obesity drug market.
-
Wegovy Pill Copy: Hims & Hers Shakes Weight-Loss Drug Market
Telehealth company Hims & Hers announced it will offer a $49 copy of Novo Nordisk’s popular Wegovy pill, causing significant shifts in the stock market for major pharmaceutical firms.
-
Robbie Williams Raises Alarm Over Vision Loss Linked to Weight-Loss Jabs
Robbie Williams, the pop icon and former Take That star, has publicly revealed his fears of going blind, attributing his deteriorating eyesight to the weight-loss medication Mounjaro. His candid account urges fans and patients to research potential risks, as medical…